薤香方湿化氧疗佐治不稳定性心绞痛（痰浊壅滞证）的临床观察

发布时间：2018-03-22 20:35

本文选题：湿化氧疗　切入点：不稳定性心绞痛　出处：《南京中医药大学》2015年硕士论文　论文类型：学位论文

【摘要】：目的：观察薤香方湿化氧疗对冠心病不稳定性心绞痛(痰浊壅滞证)患者近期临床疗效、心绞痛症状记分、中医证候积分及心电图的变化,分析薤香方湿化氧疗对不稳定性心绞痛的临床疗效。方法：根据本次试验纳入标准,选择符合标准的冠心病不稳定性心绞痛(痰浊壅滞证)患者共60例,随机分为对照组(西医常规治疗+氧疗)与治疗组(西医常规治疗+薤香方湿化氧疗),两组各30例患者。对照组参照冠心病不稳定心绞痛治疗指南常规给药,给予双重抗血小板、抗凝、抗心肌缺血、他汀类药物降脂等治疗,外加氧疗,每日2次,每次30分钟。治疗组在对照组的基础上加用薤香方(组方：薤白5g、石菖蒲5g、木香3g、降香3g、)湿化氧疗,每日2次,每次30分钟,两组疗程均为1周。观察患者心绞痛症状、心绞痛症状记分、中医证候积分及心电图的变化。结果：两组患者在性别、年龄、合并症、心绞痛分型、心绞痛危险程度分层、治疗前心绞痛症状记分及中医证候积上无统计学差异(P0.05),均具有可比性。经治疗后,两组在心绞痛症状、中医症候方面均有所改善；两组间心绞痛症状比较无差异性,在心电图方面改善也不明显(P0.05),治疗组中医证候变化较对照组明显改善(P0.05)。本次治疗过程中薤香方湿化氧疗组未发生不良反应。结论：薤香方湿化氧疗可改善冠心病不稳定性心绞痛(痰浊壅滞证)患者临床症状,临床上可作为冠心病不稳定性心绞痛(痰浊壅滞证)的辅佐治疗,值得推广应用。
[Abstract]:Objective: to observe the changes of short-term clinical effect, symptom score of angina pectoris, TCM syndromes integral and electrocardiogram in patients with unstable angina pectoris of coronary heart disease (CHD) treated by humidification oxygen therapy of Xiexixiang recipe. To analyze the clinical effect of Xiexiangfang humidification oxygen therapy on unstable angina pectoris. Methods: 60 patients with coronary heart disease with unstable angina pectoris (stagnation of phlegm and turbidity) were selected according to the criteria of this trial. They were randomly divided into two groups: control group (routine treatment of western medicine) and treatment group (routine western medicine treatment of Xiexiangfang humidified oxygen therapy), with 30 patients in each group. The control group was given regularly according to the guidelines for the treatment of coronary heart disease and unstable angina pectoris. Double antiplatelet, anticoagulant, anti-myocardial ischemia, statins, lipid-lowering, plus oxygen therapy, twice a day, Each time 30 minutes. The treatment group in the control group on the basis of Xiexiang prescription (group: Allium macrostemon 5gg, Acorus calamus 5g, woody 3g, Jiangxiang 3g) wetting oxygen therapy, twice a day, 30 minutes each time, the two groups were treated for 1 week. Observe the symptoms of angina pectoris in the two groups, and observe the symptoms of angina pectoris in the two groups, and observe the symptoms of angina pectoris. Results: sex, age, complication, angina pectoris type, angina pectoris risk degree were stratified in the two groups. Before treatment, there was no statistical difference in the score of angina pectoris symptoms and the accumulation of TCM syndromes, both of which were comparable. After treatment, the symptoms of angina pectoris and symptoms of TCM were improved in both groups, and there was no difference between the two groups in angina pectoris symptoms. The change of TCM syndrome in the treatment group was significantly better than that in the control group. There was no adverse reaction in Xiexiang Fang humidification oxygen therapy group. Conclusion: Xiexiang prescription humidification oxygen therapy can improve coronary heart disease. The clinical symptoms of patients with unstable angina pectoris (stagnation of phlegm and turbidity), It can be used as adjuvant therapy for unstable angina pectoris of coronary heart disease (stagnation of phlegm and turbidity).
【学位授予单位】：南京中医药大学
【学位级别】：硕士
【学位授予年份】：2015
【分类号】：R541.4

【参考文献】